Oncology Archive

A building with a stone facade displays a sign that reads
M. Rizwan Khawaja, , M.D., MPH, F.A.C.P.
A building with a stone facade displays a sign that reads
A Phase 1a/1b Dose Escalation, Dose Expansion Study of SW-682 in Participants With Advanced Solid Tumors Enriched for Those With Hippo Pathway Mutations
A building with a stone facade displays a sign that reads
A Phase I/II Dose-escalation and Expansion Study Evaluating the Safety, Pharmacokinetics, and Preliminary Activity of GDC-1261 in Patients With Advanced or Metastatic Prostate Cancer
A building with a stone facade displays a sign that reads
A PROSPECTIVE LOW-INTERVENTIONAL PHASE 4 SINGLE ARM STUDY OF OCULAR ASSESSMENTS IN PATIENTS TREATED WITH TIVDAK® IN RECURRENT OR METASTATIC CERVICAL CANCER
A building with a stone facade displays a sign that reads
A Phase 2 Dose Optimization Trial Evaluating a CD46-Targeted Antibody-Drug Conjugate (FG-3246) in Patients With Metastatic Castration-Resistant Prostate Cancer
A building with a stone facade displays a sign that reads
A Study of a Selective ERBB2 Inhibitor, CGT4255, in Patients With Advanced Solid Tumors With ERBB2 Genetic Alterations or HER2 Overexpression
Internationally recognized oncology drug development leader and melanoma expert joins HonorHealth Research Institute
Pamela Jackson
A building with a stone facade displays a sign that reads
A Phase I, Open-Label, Multi-Center, First-in-Human Trial to Investigate E303, in Participants With Advanced Refractory Solid Tumors
A doctor in a white coat gestures with both hands while speaking to a seated patient in a medical office with a window in the background.
New Clinical Trial Shows Nutrition Therapy Extends Survival by 34% in Stage IV Pancreatic Cancer Patients